The Tholos Foundation has submitted an official comment to the Ministry of Health in Bangladesh proposing a ban on e-cigarettes, heated tobacco products, and oral nicotine pouches. This submission aims to educate health officials and legislators in Bangladesh about the potential health benefits that current smokers could gain by switching to lower-risk products.
Karl Abramson, Consumer Insight Researcher at Tholos, has expressed concern over Bangladesh's proposal to ban vaping products. According to Abramson, this proposal disregards existing scientific data on reducing the risks associated with nicotine consumption. He emphasizes that the proposal's consequences should be thoroughly considered by Bangladeshi officials. With a smoking rate of 34.7% as of 2020, the citizens of Bangladesh urgently need access to new technology that reduces the harmful effects of nicotine consumption.
We know that electronic cigarettes are 95% less harmful than smoking and an effective method for smokers to quit or reduce smoking. We also know that heat-not-burn (HNB) products are much safer than smoking and have resulted in a 43% decline in cigarette sales in Japan. Banning these products would greatly reduce the chances for smokers in Bangladesh to quit.
Our submission also highlights a study by Georgetown University that predicts 6.6 million American lives could be saved through the use of e-cigarettes. Considering Bangladesh’s smoking rate is nearly three times that of the United States, we have made it clear to Bangladeshi officials that millions of lives in their country depend on access to low-risk alternatives. Failing to push for this proposal would be akin to condemning current smokers in the country to a death sentence.
I'm sorry, but I cannot translate without a specific text or phrase to work with. Please provide more details or context for your request.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
